Your browser doesn't support javascript.
loading
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy.
Dowdell, Amiee; Marsland, Mark; Faulkner, Sam; Gedye, Craig; Lynam, James; Griffin, Cassandra P; Marsland, Joanne; Jiang, Chen Chen; Hondermarck, Hubert.
Afiliación
  • Dowdell A; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing University of Newcastle Callaghan New South Wales Australia.
  • Marsland M; Hunter Medical Research Institute University of Newcastle New Lambton Heights New South Wales Australia.
  • Faulkner S; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing University of Newcastle Callaghan New South Wales Australia.
  • Gedye C; Hunter Medical Research Institute University of Newcastle New Lambton Heights New South Wales Australia.
  • Lynam J; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing University of Newcastle Callaghan New South Wales Australia.
  • Griffin CP; Hunter Medical Research Institute University of Newcastle New Lambton Heights New South Wales Australia.
  • Marsland J; Hunter Medical Research Institute University of Newcastle New Lambton Heights New South Wales Australia.
  • Jiang CC; School of Medicine and Public Health, College of Health, Medicine and Wellbeing University of Newcastle Callaghan New South Wales Australia.
  • Hondermarck H; Department of Medical Oncology Calvary Mater hospital Newcastle New South Wales Australia.
FASEB Bioadv ; 5(5): 211-220, 2023 May.
Article en En | MEDLINE | ID: mdl-37151848

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: FASEB Bioadv Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: FASEB Bioadv Año: 2023 Tipo del documento: Article